Home
About
Science
Leadership Team
Partnerships
Careers
Products
Pipeline
TSX-049
Clinical Studies
TSX-049
News
Contact

TesoRx Pharma

Home
About
Science
Leadership Team
Partnerships
Careers
Products
Pipeline
TSX-049
Clinical Studies
TSX-049
News
Contact
Licensing and collaboration agreement for Japan and SE Asia for oral Testosterone

Licensing and collaboration agreement for Japan and SE Asia for oral Testosterone

Licensing Agreement for Latin America, Africa Pacific and Russia CIS for oral Testosterone

Licensing Agreement for Latin America, Africa Pacific and Russia CIS for oral Testosterone

IP Licensing agreement for proliposomal drug delivery system

IP Licensing agreement for proliposomal drug delivery system

Partnership for manufacturing hormonal drugs for clinical studies and commercial distribution

Partnership for manufacturing hormonal drugs for clinical studies and commercial distribution

1 2 3 4
Previous Next
Licensing and collaboration agreement for Japan and SE Asia for oral Testosterone
Licensing Agreement for Latin America, Africa Pacific and Russia CIS for oral Testosterone
IP Licensing agreement for proliposomal drug delivery system
Partnership for manufacturing hormonal drugs for clinical studies and commercial distribution
Back to Top

Science

Leadership Team

Pipeline

 

TesoRx Pharma, LLC.

325 Sharon Park Drive, Suite 739, Menlo Park, California, 94025

E-mail: info@tesorx.com

The TesoRx logo and TesoRx are registered trademarks of TesoRx Pharma. The LIPAC logo, LIPAC Oncology and LiPax are registered trademarks of LIPAC Oncology, a subsidiary of TesoRx. © All rights reserved.